Using social networks to encourage colorectal cancer screening among Black males
FITx3 RCT: A Pilot Randomized Controlled Trial Leveraging Social Networks to Encourage Three Peers to Complete Fecal Immunochemical Testing for Colorectal Cancer
This study is trying to see if getting Black men to encourage their friends and family to get screened for colorectal cancer can help increase screening rates in their community.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 45 Years to 75 Years |
| Sex | Male |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Trial ID | NCT05793593 on ClinicalTrials.gov |
What this trial studies
This study aims to increase colorectal cancer screening rates among Black males by leveraging peer outreach. Participants who have completed fecal immunochemical testing (FIT) will be trained to encourage their peers—friends, family, and colleagues—to also get screened. The intervention includes both the FITx3 program and colorectal cancer education. By focusing on social networks, the researchers hope to address the disparities in screening rates within the Black community.
Who should consider this trial
Good fit: Ideal candidates are Black males aged 45 to 75 who have completed FIT testing within the past year and have a network of peers who meet similar criteria.
Not a fit: Patients who do not self-identify as Black or who have already participated in the study will not benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could significantly increase colorectal cancer screening rates, leading to earlier detection and better outcomes for patients.
How similar studies have performed: Other studies have shown success in using peer outreach to improve health screening rates, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identifies as Black (inclusive of African, African-American, or Afro-Caribbean) * Male * Speaks English or French very well * Is at least 45 years of age and no greater than 75 years of age * Has completed FIT testing within the prior year * Has at least 5 close network affiliates, who are Black males, and of at least 45 years of age and no greater than 75 years of age Exclusion Criteria: * Has a household member who has already participated (or agreed to participate) * Has already been approached by a peer participating in the study (index participant) to complete FIT testing
Where this trial is running
Basking Ridge, New Jersey and 6 other locations
- Memoiral Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) — Commack, New York, United States (Recruiting)
- Memorial Sloan Kettering Westchester (All Protocol Activities) — Harrison, New York, United States (Recruiting)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (Recruiting)
- Memorial Sloan Kettering Nassau (All Protocol Activities) — Rockville Centre, New York, United States (Recruiting)
Study contacts
- Principal investigator: Francesca Gany, MD, MS — Memorial Sloan Kettering Cancer Center
- Study coordinator: Francesca Gany, MD, MS
- Email: ganyf@mskcc.org
- Phone: 646-888-8054
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.